Status:
WITHDRAWN
IRIS-Firehawk® Cohort in the IRIS-DES Registry
Lead Sponsor:
Duk-Woo Park, MD
Collaborating Sponsors:
CardioVascular Research Foundation, Korea
Conditions:
Coronary Stenosis
Coronary Disease
Eligibility:
All Genders
19+ years
Brief Summary
The objective of this study is to evaluate effectiveness and safety of Firehawk® stent in the "real world" daily practice as compared with other drug-eluting stents.
Eligibility Criteria
Inclusion
- Age 19 and more
- Patient with Firehawk® coronary stent
Exclusion
- Intervention with Firehawk® coronary stent and other drug eluting stent at the same time
- Life-expectancy less than 1 year
- Cardiac shock
Key Trial Info
Start Date :
March 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2025
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03380286
Start Date
March 1 2018
End Date
December 1 2025
Last Update
March 9 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asan Medical Center
Seoul, South Korea